Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4364108 | 4144429 | I | 4364108-1 | 20040405 | 20040513 | 20040525 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-12585527 | BRISTOL-MYERS SQUIBB COMPANY | 57 | YR | F | Y | 77 | KG | 20040525 | OT |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4364108 | 1004887103 | PS | IFOSFAMIDE | 1 | INTRAVENOUS | THERAPY DATES: 03-APR TO 05-APR-2004; WITHDRAWN ON 08-APR-2004 | |||||
| 4364108 | 1004887104 | SS | CAELYX | 2 | INTRAVENOUS |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4364108 | 1004887103 | SARCOMA |
| 4364108 | 1004887104 | SARCOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4364108 | HO |
| 4364108 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4364108 | PSYCHOTIC DISORDER |
| 4364108 | TOXIC INDUCED ENCEPHALOPATHY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4364108 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4364108 | 1004887103 | 20040403 | 20040405 | ||
| 4364108 | 1004887104 | 20040403 | 20040403 |